Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
NCT ID: NCT01982058
Last Updated: 2022-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
483 participants
INTERVENTIONAL
2011-08-18
2017-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners
NCT00503646
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment
NCT01018901
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
NCT00161252
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062
Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
NCT02050906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
B. To determine whether relationship length, pre-intervention relationship satisfaction, and men's pre-intervention masculinity moderate the effects of IEC on couples' psychological and relationship outcomes
Aim 2 A. To evaluate whether IEC has an effect on couples' communication and intimacy when compared with GHW and UC and to determine whether changes in relationship communication and intimacy mediate changes in couples' psychological and relationship outcomes.
Exploratory Aim:
A. To evaluate the impact of IEC versus GHW on physical activity and fruit and vegetable intake as well as each partner's support for the other partner's adoption of greater physical activity and more fruit and vegetable intake.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intimacy-Enhancing Couples
Patients and their partners receive communication and intimacy-enhancing intervention (IEC) once a week comprising the following five 90-minute sessions: Orientation and Stories of the Cancer Experience; Communication and Listening to Partner's concerns; Communication and Coping with Cancer Issues as a Team; Being Supportive to Solve Concerns; and Reflecting on Changes and Future Adaptation.
communication intervention
counseling intervention
questionnaire administration
General Health and Wellness
Patients and their partners receive a General Health and Wellness intervention focusing on nutrition and physical activity once a week comprising of five 90-minute sessions: Introduction and Nutrition Basics; Nutrition and Prevention of Recurrence; Nutritional Review and Introduction to Relaxation; Physical Activity Basics; Aerobics and Resistance Exercises and Wrap up.
counseling intervention
nutrition intervention
questionnaire administration
Usual Care
Patients and their partners receive standard psychological and emotional care (usual care \[UC\]) (i.e., social work consultations and referral to a psychiatrist or psychologist, if requested or deemed necessary by the attending physician).
questionnaire administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
communication intervention
counseling intervention
nutrition intervention
questionnaire administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient had surgery or initiated radiation treatment (brachytherapy or external beam radiation) or began pre-radiation Androgen deprivation therapy within the past 12 months.
* Patient is currently married or living with a partner, with relationship duration at least 1 year
* Patient and partner live within a 1 hour commuting distance to recruitment site
* Patient and partner read and speak English
* Patient has an Impact of Events Scale (IES) score greater than or equal to 16 and/or partner has an IES score greater than or equal to 17.
Exclusion Criteria
* Patient has a concurrent diagnosis of another cancer (other than non-melanoma skin cancer)
* Partner is diagnosed with cancer (other than non-melanoma skin cancer)
* Patient or partner have a significant hearing impairment
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers Cancer Institute of New Jersey
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Fox Chase Cancer Center
OTHER
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sharon Manne, PhD
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon L Manne, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Rutgers Cancer Institute of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
The University Hospital
Newark, New Jersey, United States
Garden State Urology
Whippany, New Jersey, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0220100274
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2012-00552
Identifier Type: OTHER
Identifier Source: secondary_id
131023
Identifier Type: OTHER
Identifier Source: secondary_id
0220100274
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.